Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Forbion

Forbion
VC INVESTOR TYPE
Active STATUS
11 PROFESSIONALS
130 INVESTMENTS
21 PORTFOLIO
60 EXITS
Description

Forbion is an investment firm that prefers to invest in the healthcare, life sciences, oncology and manufacturing sectors. The firm was established in 2006 and is based in Naarden, Netherlands.

Website
Investor Status
Actively Seeking New Investments
Year Founded
2006
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
  • PO Box 5187
  • 1410 AD Naarden
  • Netherlands

+31 035 000 0000

Forbion Investments (130)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Dyne Therapeutics 03-Apr-2019 Early Stage VC 0000 Pharmaceuticals Generating Revenue 0000 0000000
000000000 19-Nov-2018 00000 00000 0000 Drug Discovery Generating Revenue 00000 0000000 00.0
0000000 0000000000 02-Nov-2018 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1 000000 0000000000 00.0
000000000 00000000 25-Oct-2018 00000 00000 0000 Pharmaceuticals Clinical Trials - Phase 3 00000 0000000 00.0
000000 00000000000 10-Oct-2018 00000 00000 0000 Drug Discovery Startup 000000 0000000000 00.0
00000 000000000000 29-Aug-2018 00000 00000 000.00 Biotechnology Generating Revenue 00000-000 000000 00
0000000000 0000000 12-Apr-2018 00000 00000 000.00 Drug Discovery Generating Revenue/Not Profitable 00000-000 000000 00
00000000 000000000 04-Apr-2018 00000 00000 0000 Drug Discovery Pre-Clinical Trials 00000 0000000 00.0
NorthSea Therapeutics 12-Dec-2017 Early Stage VC 000.00 Biotechnology Clinical Trials - Phase 3 000000 00000000
Hookipa Pharma 11-Dec-2017 Later Stage VC 000.00 Biotechnology Generating Revenue/Not Profitable 000000 000 00000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Forbion’s full profile, request a free trial.

Forbion Exits (60)

Company Name Exit Date Exit Type Exit Size Status Buyers
Milestone Pharmaceuticals 13-May-2019 IPO 000.00 Completed
0000000 000000 18-Apr-2019 000 0000 Completed
00000 000000000000 30-Nov-2018 0000000000: 000000 Completed
0000000 31-Aug-2018 000000000 00000000 Completed
0000000 0000000000 01-Aug-2018 000000000000000000 00000 Completed
  • 000-000000
000000000 20-Jul-2018 000 00000 Completed
0000000 0000000000 16-Mar-2018 000000000000000000 00.000 Completed
  • 00000000
00000000 26-Oct-2017 000000000000000000 00000 Completed
  • 00000 & 00.
Argenx 18-May-2017 Public Investment 2nd Offering 00000 Completed
uniQure 31-Mar-2017 Secondary Transaction - Open Market Completed
To view this investor’s complete exits history, request access »

Forbion Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore Forbion‘s full profile, request access.

Request full access to PitchBook

Forbion Team (30)

Name Title Deals Funds Boards Office Contact
Info
Vincent van Houten Chief Financial Officer Naarden, Netherlands
Martien van Osch Co-Founding Partner & Managing Partner 00 0 0 Naarden, Netherlands
Geert-Jan Mulder MD Managing Partner and Co-Founding Partner 00 0 0 Naarden, Netherlands
Sander Slootweg Managing Partner & Co-Founder 0 0 0 Naarden, Netherlands
Holger Reithinger Ph.D General Partner 00 0 0 Munich, Germany

6 Former Team Members

You’re viewing 5 of 30 team members. Get the full list »